Acousia Therapeutics
Who owns Acousia Therapeutics?
Acousia Therapeutics is a German Biotech company, currently owned by LBBW Venture Capital since 2018 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYKey facts
Ownership history
3 ownership periods · co-invest detected
More from Creathor Venture Fund IV
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Acousia Therapeutics?
Acousia Therapeutics is currently owned by LBBW Venture Capital, Creathor Ventures and 1 other, through Creathor Venture Fund IV, since 2018.
When did LBBW Venture Capital and 2 others acquire Acousia Therapeutics?
LBBW Venture Capital and 2 others acquired Acousia Therapeutics in 2018.
Who has owned Acousia Therapeutics over time?
Acousia Therapeutics has been through 3 private-equity ownership periods: Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2012; LBBW Venture Capital · via LBBW VC Evergreen Vehicle · since 2018; Creathor Ventures · via Creathor Venture Fund IV · since 2018.